// App-Quantinova.ai

: LONG-TERM ANTICOAGULANT TREATMENT OF SPLANCHNIC VENOUS THROMBOSIS IN HIGH RISK PATIENTS: DIRECT ORAL ANTICOAGULANTS VS VITAMIN K ANTAGONISTS

Researchers

Presenter

  • Alessandra Serrao

Principal Investigators

  • Manuela Merli

  • Benedetta Lucani

  • Francesca Aprile

  • Luciano Fiori

  • Antonietta Ferretti

  • Cristina Santoro

  • Antonio Chistolini

Medical Centers

  • Sapienza, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Nephrology

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Chronic kidney disease

  • Venous thrombosis

  • Renal insufficiency

  • Solid malignancies

  • Non‐Hodgkin Lymphoma

  • Cirrhosis

  • Lymphomas

  • Idiopathic portal hypertension

Biomarkers

  • Transthyretin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved